in the biopharmaceutical manufacturing process, which may pose risks to patients via generating adverse immune responses. See also Amyloid Proteopathy Amyloidosis JUNQ and IPOD Protein aggregation predictors References Alzheimer's disease Neurodegenerative disorders Neurological disorders Structural proteins